Early intra-aortic balloon pumping following perioperative myocardial injury improves hospital and mid-term prognosis

Interact Cardiovasc Thorac Surg. 2009 Mar;8(3):310-5. doi: 10.1510/icvts.2008.190884. Epub 2008 Dec 2.

Abstract

We evaluated the impact of immediate intra-aortic balloon pumping (IABP) on hospital and mid-term outcome of coronary artery bypass graft (CABG) whenever perioperative acute complications developed. We compared clinical, biochemical, echocardiographic in-hospital results and two-year follow-up outcome of 30 low-risk (EuroSCORE<5) CABG (group A) who immediately received perioperative IABP when acute complications were suspected, to a contemporary, uncomplicated case-matched group (30 patients; Group B). Two in-hospital deaths were recorded in group A with no deaths in controls (P=0.492). Group A showed significantly higher lactate only at ICU arrival (P=0.001). Troponin I was always higher, but never reached values diagnostic for myocardial infarction (P<0.001). Worse left ventricular ejection fraction (P<0.001) and wall motion score index (P=0.008) were recorded at ICU arrival in group A, although an almost complete recovery was registered at discharge. Two-year actuarial survival was similar between the two groups (P=0.598). No differences were observed in freedom from acute myocardial infarction (P=0.503) and from overall cardiac complications (P=0.410). Early IABP should be established whenever cardiac complications are suspected, because of its beneficial impact on enzymatic leakage, myocardial recovery at echocardiography, hospital outcome, mid-term follow-up survival and freedom from cardiovascular events.

MeSH terms

  • Biomarkers / blood
  • Cardiopulmonary Bypass / adverse effects*
  • Case-Control Studies
  • Coronary Artery Bypass / adverse effects*
  • Critical Care
  • Echocardiography
  • Hospital Mortality
  • Humans
  • Intra-Aortic Balloon Pumping* / adverse effects
  • L-Lactate Dehydrogenase / blood
  • Length of Stay
  • Myocardial Contraction
  • Myocardial Stunning / etiology
  • Myocardial Stunning / mortality
  • Myocardial Stunning / physiopathology
  • Myocardial Stunning / surgery*
  • Perioperative Care
  • Recovery of Function
  • Retrospective Studies
  • Stroke Volume
  • Time Factors
  • Treatment Outcome
  • Troponin I / blood
  • Ventricular Function, Left

Substances

  • Biomarkers
  • Troponin I
  • L-Lactate Dehydrogenase